Panacea Biotec Limited is an Indian pharmaceutical company that is engaged in research, development, and manufacturing of pharmaceuticals, vaccines, and natural products.
Panacea Biotec Limited: Making India Healthier
Categories
Vaccine
Panacea Biotec Limited Q3FY23 Earnings Story
With very few suppliers in the vaccination market, this creates an opportunity for India’s leading vaccine developer – Panacea Biotec Limited. Panacea
Wockhardt posted a net loss of INR 102 Crores in Q3FY23
Drugmaker Wockhardt posted a consolidated loss of ₹102 crore for the three months ended December 31, 2022. The company posted a profit
Rossari Biotech Ltd (ROSSARI) Q2 FY23 Earnings Concall Transcript
Rossari Biotech Ltd (NSE:ROSSARI) Q2 FY23 Earnings Concall dated Nov. 07, 2022 Corporate Participants: Anoop Poojari -- Client Manager Edward Menezes --
Panacea Biotech Q1FY23 Net profit soars by 2%
Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR 132 crores
Decoding Panacea Biotec Limited: India’s leading Vaccine Developer
Summary: Universal Immunization Program (UIP) in India is one of the largest public health programs in the world. It targets vaccinating ~30.4